RenovoRx, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
RNXT on Nasdaq
Location
333 W. Santa Clara Street, Suite 900, San Jose, CA

Insiders trading volume in the past year

RenovoRx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kamran Najmabadi 10%+ Owner $1.03M Aug 25, 2021
Bank Of The West 10%+ Owner $1.02M Mar 16, 2022
Shaun Bagai Chief Executive Officer, Director $306K Jan 26, 2024
Ramtin Agah Chief Medical Officer, Director $49.6K Jan 26, 2024
K. Angela Macfarlane Director $42.8K Jan 26, 2024
Robert J. Spiegel Director $42.8K Jan 26, 2024
Laurence Marton Director $35.1K Jan 26, 2024
Paul Manners Chief Financial Officer $24.4K Aug 25, 2021
Angela Nelms Chief Operating Officer $1.15K +$1.15K Jan 19, 2024
Christopher J. Lehman Chief Financial Officer Aug 30, 2021
James M. Ahlers Chief Financial Officer Jul 15, 2022
Leesa Gentry Chief Clinical Officer Mar 6, 2024
Ron Kocak VP, Controller and PAO Feb 9, 2024
David Diamond Director Oct 1, 2023
Una S. Ryan Director Oct 1, 2023

Recent Insider Transactions by Companies or Individuals for RenovoRx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.